Third Generation EGFR TKIs for Acquired Resistance
17 feb 2016 ·
3 min. 6 sec.
![Third Generation EGFR TKIs for Acquired Resistance](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/3a33ce4c3138e5f11344948e53f503df.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Dr. Nathan Pennell, Cleveland Clinic, discusses the concept of acquired resistance and new agents designed to address it, including Rociletinib and Merelitinib.
Informazioni
Autore | cancerGRACE |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company